
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing
Hao Chi, Songyun Zhao, Jinyan Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 95
Hao Chi, Songyun Zhao, Jinyan Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 95
Showing 1-25 of 95 citing articles:
Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells
Zhijie Zhao, Yantao Ding, Lisa Jia Tran, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 69
Zhijie Zhao, Yantao Ding, Lisa Jia Tran, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 69
A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts
Qianhe Ren, Pengpeng Zhang, Haoran Lin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Qianhe Ren, Pengpeng Zhang, Haoran Lin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Integrating multiple machine learning methods to construct glutamine metabolism-related signatures in lung adenocarcinoma
Pengpeng Zhang, Shengbin Pei, Leilei Wu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 43
Pengpeng Zhang, Shengbin Pei, Leilei Wu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 43
FAM family gene prediction model reveals heterogeneity, stemness and immune microenvironment of UCEC
Hao Chi, Xinrui Gao, Zhijia Xia, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 43
Hao Chi, Xinrui Gao, Zhijia Xia, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 43
Construction of a diagnostic model for hepatitis B-related hepatocellular carcinoma using machine learning and artificial neural networks and revealing the correlation by immunoassay
Shengke Zhang, Cheng‐Lu Jiang, Lai Jiang, et al.
Tumour Virus Research (2023) Vol. 16, pp. 200271-200271
Open Access | Times Cited: 43
Shengke Zhang, Cheng‐Lu Jiang, Lai Jiang, et al.
Tumour Virus Research (2023) Vol. 16, pp. 200271-200271
Open Access | Times Cited: 43
Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review
Xinyan Wu, Zhigang Zhou, Qiang Cao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Xinyan Wu, Zhigang Zhou, Qiang Cao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq
Pengpeng Zhang, Jian-Lan Liu, Shengbin Pei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Pengpeng Zhang, Jian-Lan Liu, Shengbin Pei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, and immunotherapy response for pancreatic cancer patients
Biao Zhang, Jifeng Liu, Han Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 25
Biao Zhang, Jifeng Liu, Han Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 25
Causal relationship between immune cells and hepatocellular carcinoma: a Mendelian randomisation study
Jingyi Tang, Shengke Zhang, Lai Jiang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 13, pp. 4219-4231
Open Access | Times Cited: 12
Jingyi Tang, Shengke Zhang, Lai Jiang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 13, pp. 4219-4231
Open Access | Times Cited: 12
Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy
Jialei Weng, Zheng Wang, Zhiqiu Hu, et al.
Cancer Research (2024) Vol. 84, Iss. 11, pp. 1817-1833
Closed Access | Times Cited: 10
Jialei Weng, Zheng Wang, Zhiqiu Hu, et al.
Cancer Research (2024) Vol. 84, Iss. 11, pp. 1817-1833
Closed Access | Times Cited: 10
Glycogen metabolism-mediated intercellular communication in the tumor microenvironment influences liver cancer prognosis
YANG ZHANG, NANNAN QIN, Xue‐feng Wang, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 3, pp. 563-576
Open Access | Times Cited: 9
YANG ZHANG, NANNAN QIN, Xue‐feng Wang, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 3, pp. 563-576
Open Access | Times Cited: 9
Targeting p53 for Immune Modulation: Exploring Its Functions in Tumor Immunity and Inflammation
Hong Wu, Sarah Leng, David D. Eisenstat, et al.
Cancer Letters (2025), pp. 217614-217614
Closed Access | Times Cited: 1
Hong Wu, Sarah Leng, David D. Eisenstat, et al.
Cancer Letters (2025), pp. 217614-217614
Closed Access | Times Cited: 1
Integrated single-cell and bulk RNA sequencing revealed the molecular characteristics and prognostic roles of neutrophils in pancreatic cancer
Biao Zhang, Jiaao Sun, Hewen Guan, et al.
Aging (2023) Vol. 15, Iss. 18, pp. 9718-9742
Open Access | Times Cited: 21
Biao Zhang, Jiaao Sun, Hewen Guan, et al.
Aging (2023) Vol. 15, Iss. 18, pp. 9718-9742
Open Access | Times Cited: 21
The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy
Pengpeng Zhang, Haotian Zhang, Junjie Tang, et al.
Aging (2023) Vol. 15, Iss. 19, pp. 10305-10329
Open Access | Times Cited: 21
Pengpeng Zhang, Haotian Zhang, Junjie Tang, et al.
Aging (2023) Vol. 15, Iss. 19, pp. 10305-10329
Open Access | Times Cited: 21
PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer
Biao Zhang, Bingqian Huang, Xiaonan Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
Biao Zhang, Bingqian Huang, Xiaonan Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature
Pengpeng Zhang, Xiao Zhang, Yanan Cui, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Pengpeng Zhang, Xiao Zhang, Yanan Cui, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
A novel T-cell exhaustion-related feature can accurately predict the prognosis of OC patients
Kemiao Yuan, Songyun Zhao, Bicheng Ye, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19
Kemiao Yuan, Songyun Zhao, Bicheng Ye, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19
Molecular characteristics and therapeutic implications of Toll-like receptor signaling pathway in melanoma
Hewen Guan, Xu Chen, Jifeng Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Hewen Guan, Xu Chen, Jifeng Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Uncovering the immune microenvironment and molecular subtypes of hepatitis B-related liver cirrhosis and developing stable a diagnostic differential model by machine learning and artificial neural networks
Shengke Zhang, Cheng‐Lu Jiang, Lai Jiang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 18
Shengke Zhang, Cheng‐Lu Jiang, Lai Jiang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 18
Artificial intelligence applied to ‘omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatment
Soumita Ghosh, Xun Zhao, Mouaid Alim, et al.
Gut (2024), pp. gutjnl-331740
Open Access | Times Cited: 7
Soumita Ghosh, Xun Zhao, Mouaid Alim, et al.
Gut (2024), pp. gutjnl-331740
Open Access | Times Cited: 7
Unravelling infiltrating T‐cell heterogeneity in kidney renal clear cell carcinoma: Integrative single‐cell and spatial transcriptomic profiling
Haiqing Chen, Haoyuan Zuo, Jinbang Huang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 12
Open Access | Times Cited: 6
Haiqing Chen, Haoyuan Zuo, Jinbang Huang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 12
Open Access | Times Cited: 6
Alterations of the gut microbiota associated with the occurrence and progression of viral hepatitis
Xing Yang, Huanzhuo Mai, Jie Zhou, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 13
Xing Yang, Huanzhuo Mai, Jie Zhou, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 13
Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM
Dongyun Rong, Yushen Su, Dechao Jia, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Dongyun Rong, Yushen Su, Dechao Jia, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy
Minni Zhang, Kai‐Lin Huang, Qiushi Yin, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Minni Zhang, Kai‐Lin Huang, Qiushi Yin, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma
Yuxiang Huang, Hengjian Liao, Jiefu Luo, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Yuxiang Huang, Hengjian Liao, Jiefu Luo, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access